Health Trials

Calcaneus Fractures

3

Review clinical trials related to Calcaneus Fractures. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Enhancing Wound Perfusion in High-Risk Lower Extremity Orthopaedic Surgery: A Study on Nitropaste Using Intraoperative SPY Imaging.

Enhancing Wound Perfusion in High-Risk Lower Extremity Orthopaedic Surgery: A Feasibility Study on Nitropaste Using Intraoperative SPY Imaging.

Participants needed: 15
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Mar 31, 2026Locations: 2
Eligibility criteria

Adults aged 18 years or older. [+13]

Contraindications to nitroglycerin, including known allergy. [+3]

Read more
Status: Not yet recruiting

Comparative Study Between Internal Fixtion And Primary Subtalar Arthrodesis In Comminuted Intra-Articular Calcaneal Fracture

This study is to compare clinical outcome of Sanders type III or IV intra-articular calcaneal fracture treated with open reduction and internal fixation (ORIF) versus ORIF and primary subtalar arthrodesis (PSTA).

Participants needed: 40
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Ahmed Gamal Ibrahim SalehUpdated: Feb 20, 2026
Eligibility criteria

Sanders type 3 and 4 intra articular calcaneal fracture within 14 day of injury

patient with open injury, concomitant foot injury, vascular compromise and prior...

Read more
Status: Recruiting

Opioid-Free Pain Treatment in Trauma Patients

Analgesic drug study that will compare pain outcomes of opioid analgesia and opioid-free analgesia in post-operative orthopedic patients.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of Kansas Medical CenterUpdated: Oct 26, 2024Locations: 1
Eligibility criteria

Patient is over the age of 18 years old [+1]

Patients that are unable to provide informed consent due to sustaining a head in... [+8]

Read more